Date-stamp loading
Version date: 16 December 2016 - onwards

Question 4 Research from third-country providers [Last update: 16 December 2016]

Art. 24 of MiFID II Art. 13 of the MiFID II Delegated Directive

Can investment firms accept research from third country providers that are not subject to the MiFID II requirements?

Answer 4

EU/EEA firms subject to MiFID II inducements rules must comply with these requirements (Article 24, paragraphs (7), (8) and (9), and the relevant level two provisions) irrespective of the status or geographical location of the research provider. Alternatively, they could receive research using the paying arrangements set out in Article 13 of the MiFID II Delegated Directive.

Firms should therefore treat research from a third country provider in the same way as any other third party benefits (see Q&A 3 above).

Comparing proposed amendment...